Combination of the angiogenesis inhibitor lucitanib with immune checkpoint blockade augments anti-tumor activity in syngeneic models

被引：0
|
作者：
Dusek, Rachel [1 ]
Robillard, Liliane [1 ]
Harding, Thomas [1 ]
Simmons, Andrew [1 ]
Minh Nguyen [1 ]
机构：
[1] Clovis Oncol Inc, San Francisco, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P242
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Radiation enhances anti-tumor activity of immune checkpoint blockade in syngeneic tumor models
    Urs, Sumithra
    Meade, Mary Anne
    Guley, Kevin
    Krueger, Sarah
    Wong, Alden
    Wise, Scott
    Franklin, Maryland
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade
    Liu, Xiaowei
    Feng, Yanlin
    Xu, Jie
    Shi, Ying
    Yang, Jiqiao
    Zhang, Rongjie
    Song, Jinen
    Bai, Xin
    Wu, Xi
    Bao, Yu
    Luo, Ya
    Li, Huifang
    Chai, Li
    Gong, Changyang
    Wang, Yan
    Chen, Bo
    Hu, Jianping
    Fu, Yan
    Luo, Yongzhang
    Zhang, Haiyuan
    Shi, Hubing
    JOURNAL OF CONTROLLED RELEASE, 2021, 332 : 194 - 209
  • [3] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models
    Rolland, S.
    Klinz, S. G.
    Meyer-Losic, F.
    Nahkle, J.
    Delille, R.
    de Boisferon, M. Hillairet
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
    Franklin, M.
    Thayer, M.
    Draper, D.
    Saims, D.
    Wise, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S97 - S97
  • [5] Anti-tumor Immunity and Improved Survival with Combination of Immune Checkpoint Blockade and Local Chemotherapy
    Green, J.
    Rudensky, A.
    Ariyan, C. E.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S113 - S113
  • [6] Enhancement of anti-PD-1 antitumor efficacy in syngeneic preclinical models by the angiogenesis inhibitor lucitanib
    Dusek, Rachel L.
    Robillard, Liliane
    Harding, Thomas C.
    Simmons, Andrew D.
    Minh Nguyen
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumour mouse models
    Sparks, R.
    Rolland, S.
    Klinz, S.
    Meyer-Losic, F.
    Nakhle, J.
    Delille, R.
    de Boisferonc, M. Hillairet
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
    Zheng, Weiwei
    Qian, Cheng
    Tang, Yu
    Yang, Chunmei
    Zhou, Yueke
    Shen, Peiliang
    Chen, Wenxing
    Yu, Suyun
    Wei, Zhonghong
    Wang, Aiyun
    Lu, Yin
    Zhao, Yang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Anti-tumor activity of the novel angiogenesis inhibitor anginex
    Dings, RPM
    van der Schaft, DWJ
    Hargittai, B
    Haseman, J
    Griffioen, AW
    Mayo, KH
    CANCER LETTERS, 2003, 194 (01) : 55 - 66
  • [10] Inhibition of arginase in combination with radiation therapy shows increased immune-activation and anti-tumor activity in syngeneic tumor models.
    Schuller, Alwin
    Doshi, Aatman
    Cantin, Susan
    Griffin, Matt
    San Martin, Maryann
    Proia, Theresa
    Reimer, Corinne
    Mlynarski, Scott
    Finlay, Ray
    Shao, Wenlin
    CANCER RESEARCH, 2021, 81 (13)
12345